top of page

The ABLATIA advantage

ABLATIA delivers the ablation technology digital twin for design verification and validation, leveraging advanced in silico device testing and in silico trials.

  • Highly intuitive COMSOL app, no need to be a simulation expert

  • Cloud-based with HPC for rapid iterations

  • Automatic reports for FDA premarket submissions

  • ​Future: AI-assistant & FDA-qualified MDDT

DownArrow.png

Decrease

Cost.png

 Cost 

Time.png

 Time 

UpArrow.png

Increase

SafetyNeffectiveness.png

Safety & effectiveness

SuccessProbability.png

Success probability 

TRADITIONAL PRECLINICAL HURDLES

HighCost.png

High cost

The preclinical stage for new ablation technologies costs between

$25M and $35M

consuming critical R&D budgets.

Calendar.png

Delayed market entry

Traditional validation takes

1 - 2 years 

delaying vital innovation and allowing competitor to move faster

AnimalCare.png

Ethical & fidelity issues

Trials require

18 - 50 animal sacrifices

per device, often with critical limitations in anatomical and blood perfusion fidelity

THE SOLUTION

In Silico Device Testing and Trials

Apps for multiple scenarios

Catheter inside saline/blood tank

Catheter + tissue phantom inside saline/blood tank

Simplified anatomy and blood perfusion

Realistic anatomy and blood perfusion

Our foundational expertise & impact

MathModeling.png

A robust verified mathematical modeling for PFA, RF and hybrid ablation.

guidelines.png

Ready to be refined with the FDA guidelines to become an MDDT.

presentations.png

18 indexed manuscripts and 3 Congress poster and oral presentations

cardiacAblation.png

Become part of the cardiac ablation community with multiple key connections

partners.png

Our bench of key partners for ABLATIA validation

Invest in the future of MedTech validation

Are you interested in investing in the next generation of FDA-qualified in silico trials, or eager to join our network of validating partners to shape industry standards?

bottom of page